India's pharma takes 'wait-and-watch' approach to tackle Trump's 200% tariff plan | What next?
Mint
—
Donald Trump announced a plan to bring drug manufacturing back to the U.S., imposing zero tariffs on imported generics for two years, then increasing to 100% and 200%.
Trump Plans 200% Tariff on Generic Drugs
- Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit? The Indian Express —
- Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3% Times Of India —
- Trump outlines plans for up to 200% tariffs on generic drug imports starting in 2028 Seeking Alpha —
- Trump Plans 100% Tariff on Generic Drugs From 2028 | Insight with Haslinda Amin 7/22/2026 📹 Bloomberg — · 47min
- Trump drops tariff bombshell on generic drugs with 200% threat The Independent —